Sinopharm Group (SHTDF) News Today $2.35 -0.08 (-3.09%) As of 09/17/2025 01:12 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartShort InterestBuy This Stock SHTDF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Sinopharm Group (OTCMKTS:SHTDF) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?September 13, 2025 | americanbankingnews.comSinopharm Reports Decline in H1 2025 Financial PerformanceAugust 29, 2025 | tipranks.comSinopharm Group Reports Decline in 2025 Interim ResultsAugust 24, 2025 | tipranks.comSinopharm Reports Mixed Financial Results for First Half of 2025August 20, 2025 | tipranks.comVentureBlick: MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating TheatresMay 20, 2025 | msn.comSinopharm Group: The Focus Is On Working Capital And ProfitabilityNovember 22, 2024 | seekingalpha.comSinopharm Group’s Asset Growth Boosts Investor ConfidenceOctober 28, 2024 | markets.businessinsider.comSinopharm Group Co. Reports Mixed Financial ResultsOctober 28, 2024 | markets.businessinsider.comSinopharm Group Shares Fall as Higher Costs Cut Into Quarterly ProfitApril 28, 2024 | marketwatch.comSinopharm Group Co Ltd ADR X2S1April 5, 2024 | morningstar.comMSinopharm Group Co Ltd 01099February 21, 2024 | morningstar.comMSinopharm Group Co Ltd X2SJanuary 30, 2024 | morningstar.comMSinopharm Group Co Ltd SHTDFNovember 8, 2023 | morningstar.comMSinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48May 12, 2023 | msn.comPfizer signs strategic cooperation pact with China's SinopharmApril 13, 2023 | finance.yahoo.comWHO chief expects COVID emergency to end this yearApril 6, 2023 | msn.comChina approves its first mRNA Covid-19 vaccineMarch 24, 2023 | msn.comChina approves first home-grown mRNA Covid vaccineMarch 22, 2023 | news.yahoo.comSinopharm GroupFebruary 23, 2023 | forbes.comSinopharm unit gets OK for clinical trials of mRNA COVID vaccineJanuary 20, 2023 | news.yahoo.comPharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccineJanuary 20, 2023 | msn.comSinopharm's second Chinese herb shot is potentDecember 8, 2022 | reuters.comVaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as boosterDecember 2, 2022 | seekingalpha.comMerck in pact with Sinopharm to launch oral COVID-19 therapy in ChinaSeptember 28, 2022 | seekingalpha.comSinopharm to boost local COVID vaccine production in AfricaSeptember 15, 2022 | msn.comChina’s Sinovac to test Omicron-targeting vaccines in ChileSeptember 7, 2022 | msn.comDaesang to set up joint venture with China Sinopharm InternationalJuly 27, 2022 | msn.comWeek In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology InvestmentsJuly 17, 2022 | seekingalpha.comHong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by DecemberJuly 4, 2022 | msn.comChina Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, SyringesJune 27, 2022 | msn.comSome Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese StudyJune 22, 2022 | usnews.comSome Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese studyJune 21, 2022 | reuters.comUniversity of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in NovemberMay 31, 2022 | msn.comCanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?May 28, 2022 | seekingalpha.comSinovac Biotech's Omicron-specific vaccine cleared for clinical trial in Hong KongApril 18, 2022 | seekingalpha.comSinopharm, Sinovac vaccine candidates for Omicron variant gets clearance for clinical trialApril 16, 2022 | msn.comSinopharm Says Second-Generation Vaccine Approved for TrialApril 3, 2022 | bloomberg.comAntibody triggered by Sinopharm COVID booster wanes after six months - studyFebruary 22, 2022 | reuters.comAbu Dhabi makes fourth doses of Pfizer and Sinopharm Covid-19 vaccines availableFebruary 8, 2022 | msn.comAll required data received for Sinopharm vaccine to be registered - SahpraFebruary 8, 2022 | msn.comSahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SAFebruary 7, 2022 | msn.comSinopharm Group Co Ltd (SHTDF)January 14, 2022 | nasdaq.comDuterte receives Sinopharm COVID-19 boosterJanuary 7, 2022 | msn.comWHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from OmicronJanuary 5, 2022 | msn.comSinopharm Covid-19 vaccine now available in MalaysiaOctober 15, 2021 | msn.comSinopharm vaccine now available at GPs, private hospitalsOctober 15, 2021 | msn.comWHO group backs third Covid-19 shot for elderly vaccinated with Sinovac or SinopharmOctober 12, 2021 | msn.comChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland ChinaSeptember 29, 2021 | businesswire.comChina’s Sinopharm Group contemplates vaccine plant in SLSeptember 9, 2021 | msn.comDuopharma denies appointing Bintai Healthcare, other parties as distributor of Sinopharm's Covid-19 vaccineSeptember 8, 2021 | msn.com Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SHTDF Media Mentions By Week SHTDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHTDF News Sentiment▼-0.130.63▲Average Medical News Sentiment SHTDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHTDF Articles This Week▼10▲SHTDF Articles Average Week Get the Latest News and Ratings for SHTDF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sinopharm Group and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AALBF News Today AGRPY News Today AICAF News Today EADSF News Today AIPUY News Today AKBTY News Today AABB News Today AUTLF News Today DFRYF News Today BMDPF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHTDF) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
